Virginiamycin M1
Product Specifications
UNSPSC Description
Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL.
Target Antigen
Antibiotic; Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/virginiamycin-m1.html
Purity
99.50
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N2C(C(O[C@@H]([C@@H](/C=C/C(NC/C=C\C(C)=C\[C@H](CC(CC3=NC1=CO3)=O)O)=O)C)C(C)C)=O)=CCC2
Molecular Weight
525.59
References & Citations
[1]N Suzuki, et al. Purification and characterization of virginiamycin M1 reductase from Streptomyces virginiae. Antimicrob Agents Chemother. 1998 Nov;42(11):2985-8.|[2]Xiaoxin Xu, et al. Gold nanoparticle-based lateral flow strips for rapid and sensitive detection of Virginiamycin M1. Pages 764-777 | Received 18 Mar 2020, Accepted 27 Apr 2020,
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N6686/Virginiamycin-M1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N6686/Virginiamycin-M1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
21411-53-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
